4 | Conclusions
We reported a case of diabetes mellitus after a COVID-19 infection in healthcare worker. Diabetes mellitus may be considered a clinical manifestation of COVID-19, in the case of new-onset polyuria and polydipsia following COVID-19 infection. Furthermore, the increased risk for diabetes after acute SARS-Cov2 infection highlights the importance of COVID-19 prevention strategies. It is now time to consider new-onset diabetes as metabolic clinical sequelae of SARS-CoV-2 infection and to screen COVID-19 patients for new-onset diabetes during acute illness and after recovery. Screening and management of dysglycemia should be an integral part of clinical guidelines for COVID-19 diagnosis and follow-up. Governments and health care systems around the world should evenly be prepared to screen and manage the glycometabolic sequelae of COVID-19. Finally, reporting these types of cases can help to better understand the possible complications of COVID-19 infection and its better management.
Funding: The authors report no funding.
Acknowledgments : The authors have no acknowledgments.
Conflict of interest: The authors declare that they have no conflict of interest.
Ethics statement: The patient gave his oral consent for publication of the case.
Written Consent from the patient : None